← Leaderboards
Eleanor B McGowan
Aurazyme Pharmaceuticals, Inc.
$460,983
Attributed
$460,983
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$460,983 · 2
By mechanism
R43$460,983 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsArtery OcclusionBiomarkerBiotherapeutic AgentBlood CoagulationChemical Registry /ResourceClotting FactorDrug Delivery SystemsDrug Design /Synthesis /ProductionDrug Screening /EvaluationFibrinolytic AgentsImmunologic Substance Development /PreparationLaboratory RabbitMonoclonal AntibodyNonhuman Therapy EvaluationPaclitaxelPlasminProdrugsScid MouseThrombosis